Caliber Wealth Management LLC KS Sells 1,026 Shares of Cardinal Health, Inc. $CAH

Caliber Wealth Management LLC KS decreased its holdings in Cardinal Health, Inc. (NYSE:CAH) by 24.3% during the 2nd quarter, HoldingsChannel reports. The firm owned 3,200 shares of the company’s stock after selling 1,026 shares during the quarter. Caliber Wealth Management LLC KS’s holdings in Cardinal Health were worth $538,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently modified their holdings of CAH. Wellington Management Group LLP increased its stake in shares of Cardinal Health by 1,666.7% in the 1st quarter. Wellington Management Group LLP now owns 2,384,192 shares of the company’s stock valued at $328,470,000 after purchasing an additional 2,249,241 shares during the last quarter. JPMorgan Chase & Co. increased its stake in shares of Cardinal Health by 40.0% in the 1st quarter. JPMorgan Chase & Co. now owns 4,175,992 shares of the company’s stock valued at $575,327,000 after purchasing an additional 1,193,983 shares during the last quarter. Zurich Insurance Group Ltd FI increased its stake in shares of Cardinal Health by 4,935.9% in the 1st quarter. Zurich Insurance Group Ltd FI now owns 946,750 shares of the company’s stock valued at $130,434,000 after purchasing an additional 927,950 shares during the last quarter. Nuveen LLC acquired a new stake in shares of Cardinal Health during the 1st quarter valued at $106,065,000. Finally, T. Rowe Price Investment Management Inc. acquired a new stake in shares of Cardinal Health during the 1st quarter valued at $104,951,000. Institutional investors own 87.17% of the company’s stock.

Insider Transactions at Cardinal Health

In other news, insider Ola M. Snow sold 28,151 shares of Cardinal Health stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $148.94, for a total value of $4,192,809.94. Following the completion of the transaction, the insider directly owned 15,431 shares of the company’s stock, valued at approximately $2,298,293.14. This trade represents a 64.59% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider Jessica L. Mayer sold 38,078 shares of Cardinal Health stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $148.82, for a total value of $5,666,767.96. Following the completion of the transaction, the insider directly owned 48,457 shares of the company’s stock, valued at approximately $7,211,370.74. This trade represents a 44.00% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders sold 271,676 shares of company stock worth $40,489,525. Corporate insiders own 0.12% of the company’s stock.

Cardinal Health Trading Up 0.6%

Shares of CAH opened at $159.62 on Thursday. The company has a market capitalization of $37.92 billion, a PE ratio of 24.75, a PEG ratio of 1.34 and a beta of 0.71. Cardinal Health, Inc. has a 12 month low of $106.98 and a 12 month high of $168.44. The stock’s 50-day moving average price is $152.33 and its two-hundred day moving average price is $152.20.

Cardinal Health (NYSE:CAH) last announced its earnings results on Tuesday, August 12th. The company reported $2.08 EPS for the quarter, topping the consensus estimate of $2.03 by $0.05. The firm had revenue of $60.16 billion for the quarter, compared to the consensus estimate of $60.91 billion. Cardinal Health had a negative return on equity of 74.45% and a net margin of 0.70%.The business’s quarterly revenue was up .5% compared to the same quarter last year. During the same period in the previous year, the business earned $1.84 EPS. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. Equities research analysts predict that Cardinal Health, Inc. will post 7.95 EPS for the current fiscal year.

Cardinal Health Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Wednesday, October 15th. Shareholders of record on Wednesday, October 1st were issued a dividend of $0.5107 per share. The ex-dividend date of this dividend was Wednesday, October 1st. This represents a $2.04 annualized dividend and a yield of 1.3%. Cardinal Health’s payout ratio is presently 31.63%.

Analyst Ratings Changes

Several equities research analysts recently weighed in on the company. Jefferies Financial Group set a $150.00 price objective on Cardinal Health in a report on Tuesday, August 12th. UBS Group reissued a “buy” rating on shares of Cardinal Health in a report on Tuesday, August 12th. Evercore ISI cut their price objective on Cardinal Health from $200.00 to $190.00 and set an “outperform” rating on the stock in a report on Wednesday, August 13th. Wells Fargo & Company reissued an “overweight” rating and set a $185.00 price objective (up previously from $183.00) on shares of Cardinal Health in a report on Wednesday, August 13th. Finally, Argus set a $189.00 price objective on Cardinal Health in a report on Friday, August 22nd. Twelve research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $166.00.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.